{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:18:36Z","timestamp":1769123916856,"version":"3.49.0"},"reference-count":133,"publisher":"Bentham Science Publishers Ltd.","issue":"15","funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["4005059"],"award-info":[{"award-number":["4005059"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2023,8,9]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Adaptive responses to stressful stimuli in the environment are believed to restore homeostasis\nafter stressful events. Stress activates the hypothalamic-pituitary-adrenocortical (HPA) axis,\nwhich releases glucocorticoids (GCs) into the bloodstream. Recently, agmatine, an endogenous\nmonoamine was discovered to have the potential as a pharmacotherapy for stress. Agmatine is released\nin response to certain stress conditions, especially those involving GCs, and participates in\nestablishing homeostasis disturbed by stress following GC activation. The therapeutic potential of\nagmatine for the management of psychological diseases involving stress and depression is promising\nbased on a significant amount of literature. When exogenously applied, agmatine leads to reductions\nin levels of GCs and counteracts stress-related morphologic, synaptic, and molecular changes.\nHowever, the exact mechanism of action by which agmatine modifies the effects resulting from\nstress hormone secretion is not fully understood. This review aims to present the most possible\nmechanisms by which agmatine reduces the harmful effects of chronic and acute stress. Several\nstudies suggest chronic stress exposure and repeated corticosteroid treatment lower agmatine levels,\ncontributing to stress-related symptoms. Agmatine acts as an antistress agent by activating mTOR\nsignaling, inhibiting NMDA receptors, suppressing iNOS, and maintaining bodyweight by activating\n\u03b1-2adrenergic receptors. Exogenous administration that restores agmatine levels may provide\nprotection against stress-induced changes by reducing GCs release, stimulating anti-inflammatory\nprocesses, and releasing neuroprotective factors, which are not found in all therapies currently being\nused to treat stress-related disorders. The administration of exogenous agmatine should also be considered\na therapeutic element that is capable of triggering a neural protective response that counters\nthe effects of chronic stress. When combined with existing treatment strategies, this may have synergistic\nbeneficial effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557523666230125104753","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T12:02:10Z","timestamp":1674648130000},"page":"1560-1574","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Perspectives on Agmatine Neurotransmission in Acute and Chronic Stressrelated\nConditions"],"prefix":"10.2174","volume":"23","author":[{"given":"Amin","family":"Hassanshahi","sequence":"first","affiliation":[{"name":"Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monavareh","family":"Soti","sequence":"additional","affiliation":[{"name":"Intracellular Recording Lab, Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University\nof Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Ranjbar","sequence":"additional","affiliation":[{"name":"Intracellular Recording Lab, Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University\nof Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moazamehosadat","family":"Razavinasab","sequence":"additional","affiliation":[{"name":"Intracellular Recording Lab, Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University\nof Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynab","family":"Pirmoradi","sequence":"additional","affiliation":[{"name":"Intracellular Recording Lab, Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University\nof Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi Anne","family":"Kohlmeier","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology, Faculty of Health Sciences,\nUniversity of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahyar","family":"Janahmadi","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[{"name":"Intracellular Recording Lab, Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University\nof Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1152\/physrev.00041.2006","volume":"87","author":"McEwen B.S.","year":"2007","unstructured":"McEwen B.S.; Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007,87(3),873-904","journal-title":"Physiol Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","volume":"24","author":"Herman J.P.","year":"2003","unstructured":"Herman J.P.; Figueiredo H.; Mueller N.K.; Ulrich-Lai Y.; Ostrander M.M.; Choi D.C.; Cullinan W.E.; Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo\u2013pituitary\u2013adrenocortical responsiveness. Front Neuroendocrinol 2003,24(3),151-180","journal-title":"Front Neuroendocrinol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1196\/annals.1304.012","volume":"1009","author":"Aricioglu F.","year":"2003","unstructured":"Aricioglu F.; Regunathan S.; Piletz J.E.; Is agmatine an endogenous factor against stress? Ann N Y Acad Sci 2003,1009(1),127-132","journal-title":"Ann N Y Acad Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.pnpbp.2005.08.006","volume":"29","author":"Herman J.P.","year":"2005","unstructured":"Herman J.P.; Ostrander M.M.; Mueller N.K.; Figueiredo H.; Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005,29(8),1201-1213","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","volume":"6","author":"de Kloet E.R.","year":"2005","unstructured":"de Kloet E.R.; Jo\u00ebls M.; Holsboer F.; Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005,6(6),463-475","journal-title":"Nat Rev Neurosci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2174\/187152706778559336","volume":"5","author":"Armario A.","year":"2006","unstructured":"Armario A.; The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors? CNS Neurol Disord Drug Targets 2006,5(5),485-501","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","volume":"23","author":"Holsboer F.","year":"2000","unstructured":"Holsboer F.; The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000,23(5),477-501","journal-title":"Neuropsychopharmacology"},{"key":"ref=8","first-page":"51","volume":"37","author":"de Kloet E.R.","year":"2003","unstructured":"de Kloet E.R.; Hormones, brain and stress. Endocr Regul 2003,37(2),51-68","journal-title":"Endocr Regul"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cphy.c140065","volume":"5","author":"Keller-Wood M.","year":"2015","unstructured":"Keller-Wood M.; hypothalamic-pituitary-adrenal axis-feedback control. Compr Physiol 2015,5(3),1161-1182","journal-title":"Compr Physiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/j.1460-9568.2008.06104.x","volume":"27","author":"Zhu M.Y.","year":"2008","unstructured":"Zhu M.Y.; Wang W.P.; Cai Z.W.; Regunathan S.; Ordway G.; Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain. Eur J Neurosci 2008,27(6),1320-1332","journal-title":"Eur J Neurosci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbagen.2003.11.006","volume":"1670","author":"Zhu M.","year":"2004","unstructured":"Zhu M.; Iyo A.; Piletz J.E.; Regunathan S.; Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine. Biochim Biophys Acta, Gen Subj 2004,1670(2),156-164","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.2174\/1570159X15666170808120633","volume":"16","author":"Xu W.","year":"2018","unstructured":"Xu W.; Gao L.; Li T.; Shao A.; Zhang J.; Neuroprotective role of agmatine in neurological diseases. Curr Neuropharmacol 2018,16(9),1296-1305","journal-title":"Curr Neuropharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"Piletz J.E.","year":"2013","unstructured":"Piletz J.E.; Aricioglu F.; Cheng J.T.; Fairbanks C.A.; Gilad V.H.; Haenisch B.; Halaris A.; Hong S.; Lee J.E.; Li J.; Liu P.; Molderings G.J.; Rodrigues A.L.S.; Satriano J.; Seong G.J.; Wilcox G.; Wu N.; Gilad G.M.; Agmatine: clinical applications after 100 years in translation. Drug Discov Today 2013,18(17-18),880-893","journal-title":"Drug Discov Today"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","volume":"21","author":"Reis D.J.","year":"2000","unstructured":"Reis D.J.; Regunathan S.; Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 2000,21(5),187-193","journal-title":"Trends Pharmacol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2741\/710","volume":"E6","author":"Moretti M.","year":"2014","unstructured":"Moretti M.; Matheus F.C.; de Oliveira P.A.; Neis V.B.; Ben J.; Walz R.; Rodrigues A.L.; Prediger R.D.; Role of agmatine in neurodegenerative diseases and epilepsy. Front Biosci (Elite Ed) 2014,E6(2),341-359","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.physbeh.2005.05.004","volume":"85","author":"Aricioglu F.","year":"2005","unstructured":"Aricioglu F.; Regunathan S.; Agmatine attenuates stress- and lipopolysaccharide-induced fever in rats. Physiol Behav 2005,85(3),370-375","journal-title":"Physiol Behav"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/0024-3205(95)00226-V","volume":"56","author":"Raasch W.","year":"1995","unstructured":"Raasch W.; Regunathan S.; Li G.; Reis D.J.; Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci 1995,56(26),2319-2330","journal-title":"Life Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.phrs.2003.10.008","volume":"49","author":"Raghavan S.","year":"2004","unstructured":"Raghavan S.; Dikshit M.; Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res 2004,49(5),397-414","journal-title":"Pharmacol Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00726-014-1825-9","volume":"46","author":"Popolo A.","year":"2014","unstructured":"Popolo A.; Adesso S.; Pinto A.; Autore G.; Marzocco S.; l-Arginine and its metabolites in kidney and cardiovascular disease. Amino Acids 2014,46(10),2271-2286","journal-title":"Amino Acids"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neubiorev.2011.08.006","volume":"36","author":"Uzbay T.I.","year":"2012","unstructured":"Uzbay T.I.; The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 2012,36(1),502-519","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2210-10-11","volume":"10","author":"Wang C.C.","year":"2010","unstructured":"Wang C.C.; Chio C.C.; Chang C.H.; Kuo J.R.; Chang C.P.; Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. BMC Pharmacol 2010,10(1),11","journal-title":"BMC Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.brainres.2006.02.024","volume":"1084","author":"Wang W.P.","year":"2006","unstructured":"Wang W.P.; Iyo A.H.; Miguel-Hidalgo J.; Regunathan S.; Zhu M.Y.; Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res 2006,1084(1),210-216","journal-title":"Brain Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1471-4159.2005.03544.x","volume":"96","author":"Iyo A.H.","year":"2006","unstructured":"Iyo A.H.; Zhu M.Y.; Ordway G.A.; Regunathan S.; Expression of arginine decarboxylase in brain regions and neuronal cells. J Neurochem 2006,96(4),1042-1050","journal-title":"J Neurochem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.brainres.2017.03.004","volume":"1663","author":"Gawali N.B.","year":"2017","unstructured":"Gawali N.B.; Bulani V.D.; Gursahani M.S.; Deshpande P.S.; Kothavade P.S.; Juvekar A.R.; Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway. Brain Res 2017,1663,66-77","journal-title":"Brain Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainres.2017.12.013","volume":"1680","author":"Zheng T.","year":"2018","unstructured":"Zheng T.; Zhang R.; Zhang T.; Zhang M.N.; Xu B.; Song J.; Li N.; Tang H.H.; Wang P.; Wang R.; Fang Q.; CB 1 cannabinoid receptor agonist mouse VD-hemopressin(\u03b1) produced supraspinal analgesic activity in the preclinical models of pain. Brain Res 2018,1680,155-164","journal-title":"Brain Res"},{"key":"ref=26","first-page":"581","volume":"272","author":"Piletz J.E.","year":"1995","unstructured":"Piletz J.E.; Chikkala D.N.; Ernsberger P.; Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 1995,272(2),581-587","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1749-6632.1999.tb09392.x","volume":"881","author":"Halaris A.","year":"1999","unstructured":"Halaris A.; Zhu H.; Feng Y.; Piletz J.; Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci 1999,881(1 IMIDAZOLINE R),445-451","journal-title":"Ann N Y Acad Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","volume":"21","author":"Halaris A.","year":"2007","unstructured":"Halaris A.; Plietz J.; Agmatine. CNS Drugs 2007,21(11),885-900","journal-title":"CNS Drugs"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1097\/TA.0b013e31820932e2","volume":"71","author":"Kuo J.R.","year":"2011","unstructured":"Kuo J.R.; Lo C.J.; Chang C.P.; Lin K.C.; Lin M.T.; Chio C.C.; Agmatine-promoted angiogenesis, neurogenesis, and inhibition of gliosis-reduced traumatic brain injury in rats. J Trauma 2011,71(4),E87-E93","journal-title":"J Trauma"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1046\/j.1471-4159.1997.69062421.x","volume":"69","author":"Sastre M.","year":"1997","unstructured":"Sastre M.; Regunathan S.; Reis D.J.; Uptake of agmatine into rat brain synaptosomes: Possible role of cation channels. J Neurochem 1997,69(6),2421-2426","journal-title":"J Neurochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(97)01200-6","volume":"787","author":"Otake K.","year":"1998","unstructured":"Otake K.; Ruggiero D.A.; Regunathan S.; Wang H.; Milner T.A.; Reis D.J.; Regional localization of agmatine in the rat brain: An immunocytochemical study. Brain Res 1998,787(1),1-14","journal-title":"Brain Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","volume":"57","author":"Taksande B.G.","year":"2009","unstructured":"Taksande B.G.; Kotagale N.R.; Tripathi S.J.; Ugale R.R.; Chopde C.T.; Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 2009,57(4),415-424","journal-title":"Neuropharmacology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","volume":"26","author":"Neis V.B.","year":"2016","unstructured":"Neis V.B.; Moretti M.; Bettio L.E.B.; Ribeiro C.M.; Rosa P.B.; Gon\u00e7alves F.M.; Lopes M.W.; Leal R.B.; Rodrigues A.L.S.; Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling. Eur Neuropsychopharmacol 2016,26(6),959-971","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/bj3160247","volume":"316","author":"Galea E.","year":"1996","unstructured":"Galea E.; Regunathan S.; Eliopoulos V.; Feinstein D.L.; Reis D.J.; Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996,316(1),247-249","journal-title":"Biochem J"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1527-3466.2004.tb00128.x","volume":"22","author":"Berkels R.","year":"2004","unstructured":"Berkels R.; Taubert D.; Gr\u00fcndemann D.; Sch\u00f6mig, E. Agmatine signaling: odds and threads. Cardiovasc Drug Rev 2004,22(1),7-16","journal-title":"Cardiovasc Drug Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/exnr.2001.7746","volume":"171","author":"Gorbatyuk O.S.","year":"2001","unstructured":"Gorbatyuk O.S.; Milner T.A.; Wang G.; Regunathan S.; Reis D.J.; Localization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nuclei. Exp Neurol 2001,171(2),235-245","journal-title":"Exp Neurol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(02)02260-6","volume":"932","author":"Wang G.","year":"2002","unstructured":"Wang G.; Gorbatyuk O.S.; Dayanithi G.; Ouyang W.; Wang J.; Milner T.A.; Regunathan S.; Reis D.J.; Evidence for endogenous agmatine in hypothalamo-neurohypophysial tract and its modulation on vasopressin release and Ca2+ channels. Brain Res 2002,932(1-2),25-36","journal-title":"Brain Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/j.1471-4159.2007.04867.x","volume":"103","author":"Zhu M.Y.","year":"2007","unstructured":"Zhu M.Y.; Wang W.P.; Huang J.; Regunathan S.; Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels. J Neurochem 2007,103(5),1811-1820","journal-title":"J Neurochem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2013.10.041","volume":"720","author":"Taksande B.G.","year":"2013","unstructured":"Taksande B.G.; Faldu D.S.; Dixit M.P.; Sakaria J.N.; Aglawe M.M.; Umekar M.J.; Kotagale N.R.; Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice. Eur J Pharmacol 2013,720(1-3),115-120","journal-title":"Eur J Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pbb.2015.03.005","volume":"132","author":"Taksande B.G.","year":"2015","unstructured":"Taksande B.G.; Chopde C.T.; Umekar M.J.; Kotagale N.R.; Agmatine attenuates hyperactivity and weight loss associated with activity-based anorexia in female rats. Pharmacol Biochem Behav 2015,132,136-141","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pnpbp.2013.12.012","volume":"50","author":"Freitas A.E.","year":"2014","unstructured":"Freitas A.E.; Bettio L.E.B.; Neis V.B.; Santos D.B.; Ribeiro C.M.; Rosa P.B.; Farina M.; Rodrigues A.L.S.; Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. Prog Neuropsychopharmacol Biol Psychiat 2014,50,143-150","journal-title":"Prog Neuropsychopharmacol Biol Psychiat"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/10253890.2018.1561847","volume":"22","author":"Baltzer Nielsen S.","year":"2019","unstructured":"Baltzer Nielsen S.; Stanislaus S.; Saunam\u00e4ki, K.; Gr\u00f8ndahl, C.;\nBanner, J.; J\u00f8rgensen, M.B. Can acute stress be fatal? A systematic cross-disciplinary review. Stress 2019,22(3),286-294","journal-title":"Stress"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bja\/85.1.109","volume":"85","author":"Desborough J.P.","year":"2000","unstructured":"Desborough J.P.; The stress response to trauma and surgery. Br J Anaesth 2000,85(1),109-117","journal-title":"Br J Anaesth"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4081\/ijas.2009.s1.265","volume":"8","author":"Trevisi E.","year":"2009","unstructured":"Trevisi E.; Bertoni G.; Some physiological and biochemical methods for acute and chronic stress evaluationin dairy cows. Ital J Anim Sci 2009,8(sup1),265-286","journal-title":"Ital J Anim Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1074\/jbc.270.2.815","volume":"270","author":"Sabers C.J.","year":"1995","unstructured":"Sabers C.J.; Martin M.M.; Brunn G.J.; Williams J.M.; Dumont F.J.; Wiederrecht G.; Abraham R.T.; Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 1995,270(2),815-822","journal-title":"J Biol Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"Lipton J.O.","year":"2014","unstructured":"Lipton J.O.; Sahin M.; The neurology of mTOR. Neuron 2014,84(2),275-291","journal-title":"Neuron"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.cmet.2016.05.009","volume":"23","author":"Kennedy B.K.","year":"2016","unstructured":"Kennedy B.K.; Lamming D.W.; The mechanistic target of rapamycin: The grand conductor of metabolism and aging. Cell Metab 2016,23(6),990-1003","journal-title":"Cell Metab"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","volume":"62","author":"Duman R.S.","year":"2012","unstructured":"Duman R.S.; Li N.; Liu R.J.; Duric V.; Aghajanian G.; Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012,62(1),35-41","journal-title":"Neuropharmacology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1038\/s41380-021-01246-3","volume":"26","author":"Lazarevic V.","year":"2021","unstructured":"Lazarevic V.; Yang Y.; Flais I.; Svenningsson P.; Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors. Mol Psychiat 2021,26(12),7425-7435","journal-title":"Mol Psychiat"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12640-020-00212-1","volume":"38","author":"Olescowicz G.","year":"2020","unstructured":"Olescowicz G.; Sampaio T.B.; de Paula Nascimento-Castro C.; Brocardo P.S.; Gil-Mohapel J.; Rodrigues A.L.S.; Protective effects of agmatine against corticosterone-induced impairment on hippocampal mTOR signaling and cell death. Neurotox Res 2020,38(2),319-329","journal-title":"Neurotox Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pbb.2016.10.004","volume":"150-151","author":"Neis V.B.","year":"2016","unstructured":"Neis V.B.; Bettio L.E.B.; Moretti M.; Rosa P.B.; Ribeiro C.M.; Freitas A.E.; Gon\u00e7alves F.M.; Leal R.B.; Rodrigues A.L.S.; Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice. Pharmacol Biochem Behav 2016,150-151,108-114","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.5498\/wjp.v11.i11.981","volume":"11","author":"Valverde A.P.","year":"2021","unstructured":"Valverde A.P.; Camargo A.; Rodrigues A.L.S.; Agmatine as a novel candidate for rapid-onset antidepressant response. World J Psychiatry 2021,11(11),981-996","journal-title":"World J Psychiatry"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pbb.2018.08.005","volume":"173","author":"Neis V.B.","year":"2018","unstructured":"Neis V.B.; Bettio L.B.; Moretti M.; Rosa P.B.; Olescowicz G.; Fraga D.B.; Gon\u00e7alves F.M.; Freitas A.E.; Heinrich I.A.; Lopes M.W.; Leal R.B.; Rodrigues A.L.S.; Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine. Pharmacol Biochem Behav 2018,173,44-50","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"126","author":"Inoki K.","year":"2006","unstructured":"Inoki K.; Ouyang H.; Zhu T.; Lindvall C.; Wang Y.; Zhang X.; Yang Q.; Bennett C.; Harada Y.; Stankunas K.; Wang C.; He X.; MacDougald O.A.; You M.; Williams B.O.; Guan K.L.; TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006,126(5),955-968","journal-title":"Cell"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nm.3513","volume":"20","author":"Ota K.T.","year":"2014","unstructured":"Ota K.T.; Liu R.J.; Voleti B.; Maldonado-Aviles J.G.; Duric V.; Iwata M.; Dutheil S.; Duman C.; Boikess S.; Lewis D.A.; Stockmeier C.A.; DiLeone R.J.; Rex C.; Aghajanian G.K.; Duman R.S.; REDD1 is essential for stress-induced synaptic loss and depressive behavior. Nat Med 2014,20(5),531-535","journal-title":"Nat Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","volume":"13","author":"Zomkowski A.D.E.","year":"2002","unstructured":"Zomkowski A.D.E.; Hammes L.; Lin J.; Calixto J.B.; Santos A.R.S.; Rodrigues A.L.S.; Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002,13(4),387-391","journal-title":"Neuroreport"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","volume":"130","author":"Neis V.B.","year":"2015","unstructured":"Neis V.B.; Moretti M.; Manosso L.M.; Lopes M.W.; Leal R.B.; Rodrigues A.L.S.; Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice. Pharmacol Biochem Behav 2015,130,9-14","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e852","DOI":"10.1038\/tp.2016.116","volume":"6","author":"Meylan E.M.","year":"2016","unstructured":"Meylan E.M.; Breuillaud L.; Seredenina T.; Magistretti P.J.; Halfon O.; Luthi-Carter R.; Cardinaux J-R.; Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression. Transl Psychiatry 2016,6(7),e852","journal-title":"Transl Psychiatry"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/sj.bjp.0702679","volume":"127","author":"Olmos G.","year":"1999","unstructured":"Olmos G.; DeGregorio-Rocasolano N.; Regalado M.P.; Gasull T.; Boronat M.A.; Trullas R.; Villarroel A.; Lerma J.; Garc\u00eda-\nSevilla, J.A. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 1999,127(6),1317-1326","journal-title":"Br J Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3346\/jkms.2015.30.7.943","volume":"30","author":"Kim J.Y.","year":"2015","unstructured":"Kim J.Y.; Lee Y.W.; Kim J.H.; Lee W.T.; Park K.A.; Lee J.E.; Agmatine attenuates brain edema and apoptotic cell death after traumatic brain injury. J Korean Med Sci 2015,30(7),943-952","journal-title":"J Korean Med Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0006-8993(00)02517-8","volume":"872","author":"Abe K.","year":"2000","unstructured":"Abe K.; Abe Y.; Saito H.; Agmatine suppresses nitric oxide production in microglia. Brain Res 2000,872(1-2),141-148","journal-title":"Brain Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","volume":"53","author":"Peineau S.","year":"2007","unstructured":"Peineau S.; Taghibiglou C.; Bradley C.; Wong T.P.; Liu L.; Lu J.; Lo E.; Wu D.; Saule E.; Bouschet T.; Matthews P.; Isaac J.T.R.; Bortolotto Z.A.; Wang Y.T.; Collingridge G.L.; LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 2007,53(5),703-717","journal-title":"Neuron"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.biopsych.2012.11.011","volume":"73","author":"Dwyer J.M.","year":"2013","unstructured":"Dwyer J.M.; Duman R.S.; Activation of mammalian target of rapamycin and synaptogenesis: Role in the actions of rapid-acting antidepressants. Biol Psychiatry 2013,73(12),1189-1198","journal-title":"Biol Psychiatry"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1523\/JNEUROSCI.0346-21.2021","volume":"41","author":"Zhou J.J.","year":"2021","unstructured":"Zhou J.J.; Shao, J.Y.; Chen, S.R.; Li, D.P.; Pan, H.L. \u03b12\u03b4-1\u2013dependent nmda receptor activity in the hypothalamus is an effector of genetic-environment interactions that drive persistent hypertension. J Neurosci 2021,41(30),6551-6563","journal-title":"J Neurosci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1210\/en.2017-03176","volume":"159","author":"Zhou J.J.","year":"2018","unstructured":"Zhou J.J.; Gao Y.; Zhang X.; Kosten T.A.; Li D.P.; Enhanced hypothalamic NMDA receptor activity contributes to hyperactivity of HPA axis in chronic stress in male rats. Endocrinology 2018,159(3),1537-1546","journal-title":"Endocrinology"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1601-183X.2010.00619.x","volume":"9","author":"Middeldorp C.M.","year":"2010","unstructured":"Middeldorp C.M.; Slof-Op \u2019t Landt M.C.T.; Medland S.E.; van Beijsterveldt C.E.M.; Bartels M.; Willemsen G.; Hottenga J.J.; de Geus E.J.C.; Suchiman H.E.D.; Dolan C.V.; Neale M.C.; Slagboom P.E.; Boomsma D.I.; Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes? Genes Brain Behav 2010,9(7),808-816","journal-title":"Genes Brain Behav"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1196\/annals.1364.060","volume":"1071","author":"Uys J.D.K.","year":"2006","unstructured":"Uys J.D.K.; Marais L.; Faure J.; Prevoo D.; Swart P.; Mohammed A.H.; Stein D.J.; Daniels W.M.; Developmental trauma is associated with behavioral hyperarousal, altered HPA axis activity, and decreased hippocampal neurotrophin expression in the adult rat. Ann N Y Acad Sci 2006,1071(1),542-546","journal-title":"Ann N Y Acad Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","volume":"64","author":"Sen S.","year":"2008","unstructured":"Sen S.; Duman R.; Sanacora G.; Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008,64(6),527-532","journal-title":"Biol Psychiatry"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","volume":"7","author":"Castr\u00e9n E.","year":"2007","unstructured":"Castr\u00e9n E.; V\u00f5ikar, V.; Rantam\u00e4ki, T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007,7(1),18-21","journal-title":"Curr Opin Pharmacol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neures.2005.06.008","volume":"53","author":"Murakami S.","year":"2005","unstructured":"Murakami S.; Imbe H.; Morikawa Y.; Kubo C.; Senba E.; Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res 2005,53(2),129-139","journal-title":"Neurosci Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"Lepack A.E.","year":"2015","unstructured":"Lepack A.E.; Fuchikami M.; Dwyer J.M.; Banasr M.; Duman R.S.; BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol 2015,18(1),pyu033","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","volume":"66","author":"Abdallah C.G.","year":"2015","unstructured":"Abdallah C.G.; Sanacora G.; Duman R.S.; Krystal J.H.; Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med 2015,66(1),509-523","journal-title":"Annu Rev Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2014.09.011","volume":"36","author":"Huang K.","year":"2014","unstructured":"Huang K.; Fingar D.C.; Growing knowledge of the mTOR signaling network. Semin Cell Dev Biol 2014,36,79-90","journal-title":"Semin Cell Dev Biol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","volume":"53","author":"Freitas A.E.","year":"2016","unstructured":"Freitas A.E.; Egea J.; Buendia I.; G\u00f3mez-Rangel, V.; Parada, E.; Navarro, E.; Casas, A.I.; Wojnicz, A.; Ortiz, J.A.; Cuadrado, A.; Ruiz-Nu\u00f1o, A.; Rodrigues, A.L.S.; Lopez, M.G. Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice. Mol Neurobiol 2016,53(5),3030-3045","journal-title":"Mol Neurobiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"112692","DOI":"10.1016\/j.bbr.2020.112692","volume":"392","author":"Bilge S.S.","year":"2020","unstructured":"Bilge S.S.; G\u00fcnaydin C.; \u00d6nger, M.E.; Bozkurt, A.; Avci, B. Neuroprotective action of agmatine in rotenone-induced model of Parkinson\u2019s disease: Role of BDNF\/cREB and ERK pathway. Behav Brain Res 2020,392,112692","journal-title":"Behav Brain Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","volume":"261","author":"Neis V.B.","year":"2014","unstructured":"Neis V.B.; Manosso L.M.; Moretti M.; Freitas A.E.; Daufenbach J.; Rodrigues A.L.S.; Depressive-like behavior induced by tumor necrosis factor-\u03b1 is abolished by agmatine administration. Behav Brain Res 2014,261,336-344","journal-title":"Behav Brain Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.273.5276.801","volume":"273","author":"MacMillan L.B.","year":"1996","unstructured":"MacMillan L.B.; Hein L.; Smith M.S.; Piascik M.T.; Limbird L.E.; Central hypotensive effects of the \u03b12a-adrenergic receptor subtype. Science 1996,273(5276),801-803","journal-title":"Science"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1399-6576.1993.tb03743.x","volume":"37","author":"Aantaa R.","year":"1993","unstructured":"Aantaa R.; Scheinin M.; Alpha 2 -adrenergic agents in anaesthesia. Acta Anaesthesiol Scand 1993,37(5),433-448","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J","volume":"23","author":"Bremner J.D.","year":"1996","unstructured":"Bremner J.D.; Krystal J.H.; Southwick S.M.; Charney D.S.; Noradrenergic mechanisms in stress and anxiety: I. preclinical studies. Synapse 1996,23(1),28-38","journal-title":"Synapse"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF02246270","volume":"122","author":"Haller J.","year":"1995","unstructured":"Haller J.; Kiem D.T.; Makara G.B.; Do alpha-2 adrenoceptors modify coping strategies in rats? Psychopharmacology (Berl) 1995,122(4),379-385","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/archpsyc.1996.01830050084013","volume":"53","author":"Arnsten A.F.T.","year":"1996","unstructured":"Arnsten A.F.T.; Steere J.C.; Hunt R.D.; The contribution of \u03b1 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996,53(5),448-455","journal-title":"Arch Gen Psychiatry"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.expneurol.2003.10.007","volume":"185","author":"Ciranna L.","year":"2004","unstructured":"Ciranna L.; Licata F.; Li Volsi G.; Santangelo F.; Alpha2- and beta-adrenoceptors differentially modulate GABAA- and GABAB-mediated inhibition of red nucleus neuronal firing. Exp Neurol 2004,185(2),297-304","journal-title":"Exp Neurol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0169-328X(03)00026-3","volume":"112","author":"Zhang W.","year":"2003","unstructured":"Zhang W.; Ordway G.A.; The \u03b12C-adrenoceptor modulates GABA release in mouse striatum. Brain Res Mol Brain Res 2003,112(1-2),24-32","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neulet.2005.10.069","volume":"395","author":"Alachkar A.","year":"2006","unstructured":"Alachkar A.; Brotchie, J.; Jones, O.T. \u03b12-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata. Neurosci Lett 2006,395(2),138-142","journal-title":"Neurosci Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00432135","volume":"68","author":"Olgiati V.R.","year":"1980","unstructured":"Olgiati V.R.; Netti C.; Guidobono F.; Pecile A.; The central GABAergic system and control of food intake under different experimental conditions. Psychopharmacology (Berl) 1980,68(2),163-167","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1152\/jn.00564.2004","volume":"93","author":"Li D.P.","year":"2005","unstructured":"Li D.P.; Atnip L.M.; Chen S.R.; Pan H.L.; Regulation of synaptic inputs to paraventricular-spinal output neurons by \u03b12 adrenergic receptors. J Neurophysiol 2005,93(1),393-402","journal-title":"J Neurophysiol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1152\/jn.2002.87.5.2287","volume":"87","author":"Han S.K.","year":"2002","unstructured":"Han S.K.; Chong W.; Li L.H.; Lee I.S.; Murase K.; Ryu P.D.; Noradrenaline excites and inhibits GABAergic transmission in parvocellular neurons of rat hypothalamic paraventricular nucleus. J Neurophysiol 2002,87(5),2287-2296","journal-title":"J Neurophysiol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/plac.2001.0748","volume":"23","year":"2002","unstructured":"Divya; Chhikara, P.; Mahajan, V.S.; Datta Gupta, S.; Chauhan, S.S. Differential activity of cathepsin L in human placenta at two different stages of gestation. Placenta 2002,23(1),59-64","journal-title":"Placenta"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuroscience.2013.01.008","volume":"236","year":"2013","unstructured":"H\u00f6rtnagl, H.; Tasan, R.O.; Wieselthaler, A.; Kirchmair, E.; Sieghart, W.; Sperk, G. Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience 2013,236,345-372","journal-title":"Neuroscience"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2005.07.019","volume":"50","author":"Kokare D.M.","year":"2006","unstructured":"Kokare D.M.; Patole A.M.; Carta A.; Chopde C.T.; Subhedar N.K.; GABAA receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 2006,50(1),16-24","journal-title":"Neuropharmacology"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopha.2017.07.004","volume":"93","author":"Taksande B.G.","year":"2017","unstructured":"Taksande B.G.; Sharma O.; Aglawe M.M.; Kale M.B.; Gawande D.Y.; Umekar M.J.; Kotagale N.R.; Acute orexigenic effect of agmatine involves interaction between central \u03b12-adrenergic and GABAergic receptors. Biomed Pharmacother 2017,93,939-947","journal-title":"Biomed Pharmacother"},{"key":"ref=92","first-page":"1411","volume":"160","author":"Zhang L.","year":"2019","unstructured":"Zhang L.; Hernandez-Sanchez D.; Herzog H.; Regulation of feeding-related behaviors by arcuate neuropeptide Y neurons. Endocrinology 2019,160(6),1411-1420","journal-title":"Endocrinology"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1210\/endo.140.2.6495","volume":"140","author":"Pu S.","year":"1999","unstructured":"Pu S.; Jain M.R.; Horvath T.L.; Diano S.; Kalra P.S.; Kalra S.P.; Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 1999,140(2),933-940","journal-title":"Endocrinology"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"Hannestad J.","year":"2011","unstructured":"Hannestad J.; DellaGioia N.; Bloch M.; The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011,36(12),2452-2459","journal-title":"Neuropsychopharmacology"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","volume":"31","author":"Iwata M.","year":"2013","unstructured":"Iwata M.; Ota K.T.; Duman R.S.; The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 2013,31,105-114","journal-title":"Brain Behav Immun"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2006.08.002","volume":"126","author":"Ogura Y.","year":"2006","unstructured":"Ogura Y.; Sutterwala F.S.; Flavell R.A.; The inflammasome: first line of the immune response to cell stress. Cell 2006,126(4),659-662","journal-title":"Cell"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"NA","DOI":"10.1002\/jnr.22343","volume":"88","author":"Chakraborty S.","year":"2010","unstructured":"Chakraborty S.; Kaushik D.K.; Gupta M.; Basu A.; Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res 2010,88(8),NA","journal-title":"J Neurosci Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","volume":"36","year":"2014","unstructured":"Alcocer-G\u00f3mez, E.; de Miguel, M.; Casas-Barquero, N.; N\u00fa\u00f1ez-\nVasco, J.; S\u00e1nchez-Alcazar, J.A.; Fern\u00e1ndez-Rodr\u00edguez, A.; Cordero, M.D. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun 2014,36,111-117","journal-title":"Brain Behav Immun"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/bcpt.12604","volume":"119","author":"Sahin C.","year":"2016","unstructured":"Sahin C.; Albayrak O.; Akdeniz T.F.; Akbulut Z.; Yanikkaya Demirel G.; Aricioglu F.; agmatine reverses sub-chronic stress induced nod-like receptor protein 3 (nlrp3) activation and cytokine response in rats. Basic Clin Pharmacol Toxicol 2016,119(4),367-375","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuint.2018.05.006","volume":"118","author":"Tavares M.K.","year":"2018","unstructured":"Tavares M.K.; dos Reis S.; Platt N.; Heinrich I.A.; Wolin I.A.V.; Leal R.B.; Kaster M.P.; Rodrigues A.L.S.; Freitas A.E.; Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR\/S6 kinase signaling pathway. Neurochem Int 2018,118,275-285","journal-title":"Neurochem Int"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ejphar.2015.08.055","volume":"765","author":"Gulati K.","year":"2015","unstructured":"Gulati K.; Joshi J.C.; Ray A.; Recent advances in stress research: Focus on nitric oxide. Eur J Pharmacol 2015,765,406-414","journal-title":"Eur J Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.freeradbiomed.2005.08.047","volume":"40","author":"Hummel S.G.","year":"2006","unstructured":"Hummel S.G.; Fischer A.J.; Martin S.M.; Schafer F.Q.; Buettner G.R.; Nitric oxide as a cellular antioxidant: A little goes a long way. Free Radic Biol Med 2006,40(3),501-506","journal-title":"Free Radic Biol Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1046\/j.1471-4159.2001.00108.x","volume":"76","author":"Madrigal J.L.M.","year":"2001","unstructured":"Madrigal J.L.M.; Moro M.A.; Lizasoain I.; Lorenzo P.; Castrillo A.; Bosc\u00e1, L.; Leza, J.C. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor \u03baB-mediated mechanisms. J Neurochem 2001,76(2),532-538","journal-title":"J Neurochem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jcp.1119","volume":"188","author":"Satriano J.","year":"2001","unstructured":"Satriano J.; Schwartz D.; Ishizuka S.; Lortie M.J.; Thomson S.C.; Gabbai F.; Kelly C.J.; Blantz R.C.; Suppression of inducible nitric oxide generation by agmatine aldehyde: Beneficial effects in sepsis. J Cell Physiol 2001,188(3),313-320","journal-title":"J Cell Physiol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1254\/jjp.69.285","volume":"69","author":"Auguet M.","year":"1995","unstructured":"Auguet M.; Viossat I.; Marin J.G.; Chabrier P.E.; Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 1995,69(3),285-287","journal-title":"Jpn J Pharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1124\/mol.59.1.24","volume":"59","author":"Demady D.R.","year":"2001","unstructured":"Demady D.R.; Jianmongkol S.; Vuletich J.L.; Bender A.T.; Osawa Y.; Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol 2001,59(1),24-29","journal-title":"Mol Pharmacol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1196\/annals.1304.002","volume":"1009","author":"Regunathan S.","year":"2003","unstructured":"Regunathan S.; Piletz J.E.; Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 2003,1009(1),20-29","journal-title":"Ann N Y Acad Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0006-8993(90)90898-L","volume":"516","author":"Singh V.B.","year":"1990","unstructured":"Singh V.B.; Corley K.C.; Phan T.H.; Boadle-Biber M.C.; Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res 1990,516(1),66-76","journal-title":"Brain Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(97)01313-9","volume":"783","author":"Maswood S.","year":"1998","unstructured":"Maswood S.; Barter J.E.; Watkins L.R.; Maier S.F.; Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Brain Res 1998,783(1),115-120","journal-title":"Brain Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/sj.npp.1300206","volume":"28","author":"Bland S.T.","year":"2003","unstructured":"Bland S.T.; Hargrave D.; Pepin J.L.; Amat J.; Watkins L.R.; Maier S.F.; Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex. Neuropsychopharmacology 2003,28(9),1589-1596","journal-title":"Neuropsychopharmacology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nn1399","volume":"8","author":"Amat J.","year":"2005","unstructured":"Amat J.; Baratta M.V.; Paul E.; Bland S.T.; Watkins L.R.; Maier S.F.; Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 2005,8(3),365-371","journal-title":"Nat Neurosci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0306-4522(90)90127-P","volume":"35","author":"Pei Q.","year":"1990","unstructured":"Pei Q.; Zetterstro\u00a8m T.; Fillenz M.; Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the rat. Neuroscience 1990,35(1),133-138","journal-title":"Neuroscience"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0006-8993(93)91024-M","volume":"614","author":"Clement H.W.","year":"1993","unstructured":"Clement H.W.; Sch\u00e4fer, F.; Ruwe, C.; Gemsa, D.; Wesemann, W. Stress-induced changes of extracellular 5-hydroxyindoleacetic acid concentrations followed in the nucleus raphe dorsalis and the frontal cortex of the rat. Brain Res 1993,614(1-2),117-124","journal-title":"Brain Res"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0091-3057(94)90243-7","volume":"49","author":"Inoue T.","year":"1994","unstructured":"Inoue T.; Tsuchiya K.; Koyama T.; Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav 1994,49(4),911-920","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/026988110201600310","volume":"16","author":"Man M.S.","year":"2002","unstructured":"Man M.S.; Young A.H.; McAllister-Williams R.H.; Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice. J Psychopharmacol 2002,16(3),245-252","journal-title":"J Psychopharmacol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0165-1781(02)00250-0","volume":"113","author":"Klaassen T.","year":"2002","unstructured":"Klaassen T.; Riedel W.J.; van Praag H.M.; Menheere P.P.C.A.; Griez E.; Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res 2002,113(1-2),29-40","journal-title":"Psychiatry Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0006-8993(98)00901-9","volume":"811","year":"1998","unstructured":"J\u00f8rgensen, H.; Knigge, U.; Kj\u00e6r, A.; Vadsholt, T.; Warberg, J. Serotonergic involvement in stress-induced ACTH release. Brain Res 1998,811(1-2),10-20","journal-title":"Brain Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.2584-06.2007","volume":"27","author":"Heisler L.K.","year":"2007","unstructured":"Heisler L.K.; Pronchuk N.; Nonogaki K.; Zhou L.; Raber J.; Tung L.; Yeo G.S.H.; O\u2019Rahilly S.; Colmers W.F.; Elmquist J.K.; Tecott L.H.; Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J Neurosci 2007,27(26),6956-6964","journal-title":"J Neurosci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","volume":"1023","author":"Dias Elpo Zomkowski A.","year":"2004","unstructured":"Dias Elpo Zomkowski A.; Oscar Rosa A.; Lin J.; Santos A.R.S.; Batista Calixto J.; L\u00facia Severo Rodrigues, A. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 2004,1023(2),253-263","journal-title":"Brain Res"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0304-3940(96)13199-2","volume":"219","author":"Romero L.","year":"1996","unstructured":"Romero L.; Herv\u00e1s, I.; Artigas, F. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett 1996,219(2),123-126","journal-title":"Neurosci Lett"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s002130050846","volume":"141","author":"Redrobe J.P.","year":"1999","unstructured":"Redrobe J.P.; Bourin M.; Evidence of the activity of lithium on 5-HT 1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology (Berl) 1999,141(4),370-377","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(00)01378-1","volume":"291","author":"Smith J.C.E.","year":"2000","unstructured":"Smith J.C.E.; Whitton P.S.; Nitric oxide modulates N -methyl- d -aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neurosci Lett 2000,291(1),5-8","journal-title":"Neurosci Lett"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bbr.2007.11.013","volume":"188","author":"Krass M.","year":"2008","unstructured":"Krass M.; Wegener G.; Vasar E.; Volke V.; Antidepressant-like effect of agmatine is not mediated by serotonin. Behav Brain Res 2008,188(2),324-328","journal-title":"Behav Brain Res"},{"key":"ref=124","first-page":"722","volume":"47","author":"Wang B.X.","year":"2020","unstructured":"Wang B.X.; Effects of agmatine on spatial reference memory of mice under normal and stress conditions. J Int Pharm Res 2020,47(9),722-730","journal-title":"J Int Pharm Res"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yebeh.2017.11.005","volume":"78","author":"Bahremand T.","year":"2018","unstructured":"Bahremand T.; Payandemehr P.; Riazi K.; Noorian A.R.; Payandemehr B.; Sharifzadeh M.; Dehpour A.R.; Modulation of the anticonvulsant effect of swim stress by agmatine. Epilepsy Behav 2018,78,142-148","journal-title":"Epilepsy Behav"},{"key":"ref=126","first-page":"706","volume":"10","author":"Carlisle M.A.","year":"1996","unstructured":"Carlisle M.A.; Smvth D.D.; Glavin G.B.; Imidazoline receptor modulation of gastric acid secretion and experimental gastric mucosal injury. FASEB J 1996,10(3),706","journal-title":"FASEB J"},{"key":"ref=127","first-page":"270","volume":"32","author":"Xiong Z.","year":"2016","unstructured":"Xiong Z.; Inhibitory effects of agmatine on stress-induced hyperthermia in rats. Chine J Appl Phys 2016,32(3),270-273","journal-title":"Chine J Appl Phys"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.pnpbp.2017.08.017","volume":"81","author":"Olescowicz G.","year":"2018","unstructured":"Olescowicz G.; Neis V.B.; Fraga D.B.; Rosa P.B.; Azevedo D.P.; Melleu F.F.; Brocardo P.S.; Gil-Mohapel J.; Rodrigues A.L.S.; Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone. Prog Neuropsychopharmacol Biol Psychiatry 2018,81,395-407","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpsychires.2019.10.004","volume":"120","author":"Ozden A.","year":"2020","unstructured":"Ozden A.; Angelos H.; Feyza A.; Elizabeth W.; John P.; Altered plasma levels of arginine metabolites in depression. J Psychiatr Res 2020,120,21-28","journal-title":"J Psychiatr Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2174\/1574884714666191016152143","volume":"15","author":"Rafi H.","year":"2020","unstructured":"Rafi H.; Ahmad F.; Anis J.; Khan R.; Rafiq H.; Farhan M.; Comparative effectiveness of agmatine and choline treatment in rats with cognitive impairment induced by AlCl3 and forced swim stress. Curr Clin Pharmacol 2020,15(3),251-264","journal-title":"Curr Clin Pharmacol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"146438","DOI":"10.1016\/j.brainres.2019.146438","volume":"1725","author":"Sahin Ozkartal C.","year":"2019","unstructured":"Sahin Ozkartal C.; Tuzun E.; Kucukali C.I.; Ulusoy C.; Giris M.; Aricioglu F.; Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes. Brain Res 2019,1725,146438","journal-title":"Brain Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1745-7254.2006.00429.x","volume":"27","author":"Li Y.","year":"2006","unstructured":"Li Y.; Chen H.; Liu Y.; Zhang Y.; Liu Y.; Li J.; Agmatine increases proliferation of cultured hippocampal progenitor cells and hippocampal neurogenesis in chronically stressed mice. Acta Pharmacol Sin 2006,27(11),1395-1400","journal-title":"Acta Pharmacol Sin"},{"key":"ref=133","first-page":"21","volume":"25","author":"Chen H.X.","year":"2009","unstructured":"Chen H.X.; Effect of agmatine on the neurons and astrocytes in hippocampus of chronically stressed rats. Zhongguo Yaolixue Tongbao 2009,25(1),21-25","journal-title":"Zhongguo Yaolixue Tongbao"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666230125104753","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213129\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666230125104753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T11:34:38Z","timestamp":1695123278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213129\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":133,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557523666230125104753","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}